The role of CDK1 in apoptin-induced apoptosis in hepatocellular carcinoma cells

Zhao,Jing; Han,Su-Xia; Ma,Jin-Lu; Ying,Xia; Liu,Peijun; Li,Juan; Wang,Lijuan; Zhang,Ying; Ma,Jiguang; Zhang,Li; Zhu,Qing

doi:10.3892/or.2013.2426

The role of CDK1 in apoptin-induced apoptosis in hepatocellular carcinoma cells

Authors:
- Jing Zhao
- Su-Xia Han
- Jin-Lu Ma
- Xia Ying
- Peijun Liu
- Juan Li
- Lijuan Wang
- Ying Zhang
- Jiguang Ma
- Li Zhang
- Qing Zhu
View Affiliations

Affiliations: Department of Oncology, The First Affiliated Hospital, Xi'an Jiaotong University Medical college, Xi'an, Shaanxi 710061, P.R. China, Center for Translational Medicine, The First Affiliated Hospital, Xi'an Jiaotong University Medical college, Xi'an, Shaanxi 710061, P.R. China
Published online on: April 25, 2013 https://doi.org/10.3892/or.2013.2426
Pages: 253-259

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Apoptin, a small protein derived from the chicken anemia virus, specifically induces apoptosis in transformed cells or tumor cells but not in normal cells. Thus, apoptin is involved in a general, tumor-specific pathway. Apoptin-induced apoptosis presumably requires additional interaction partners that activate specific signaling pathways in cancer cells. A number of molecules interact with apoptin and play an important role in the nuclear localization of apoptin or its tumor-selective cytotoxicity. Our data indicated that apoptin selectively kills HepG2 hepatocellular carcinoma (HCC) cells but has no effect on the normal liver cell line HL-7702. Analyses of human HCC tissue samples confirmed that CDK1 (cyclin-dependent kinase 1) activity was detected in primary malignancies but not in healthy paraneoplastic tissues. shRNA knockdown of CDK1 significantly reduced the tumor-specific killing effects of apoptin, suggesting that CDK1 plays an important role in the regulation of apoptin-induced apoptosis. Furthermore, the majority of apoptin translocated to the cytoplasm from the nucleus after knockdown of CDK1. Collectively, our results revealed for the first time that apoptin interacts with CDK1 in the complex process of tumorigenesis. The link between CDK1 and apoptin may be a novel cellular signaling pathway to modulate apoptosis in cancer; therefore, apoptin may have pharmacological potential to be directly employed for cancer therapy.

View Figures

View References

1	Zhang Y, Wang S, Li D, et al: A systems biology-based classifier for hepatocellular carcinoma diagnosis. PloS One. 6:e224262011. View Article : Google Scholar : PubMed/NCBI
2	Almogy G, Lieberman S, Gips M, et al: Clinical outcomes of surgical resections for primary liver sarcoma in adults: results from a single centre. Eur J Surg Oncol. 30:421–427. 2004. View Article : Google Scholar : PubMed/NCBI
3	Tanaka S and Arii S: Molecularly targeted therapy for hepatocellular carcinoma. Cancer Sci. 100:1–8. 2009. View Article : Google Scholar : PubMed/NCBI
4	Noteborn MH, Todd D, Verschueren CA, et al: A single chicken anemia virus protein induces apoptosis. J Virol. 68:346–351. 1994.PubMed/NCBI
5	Noteborn MH, de Boer GF, van Roozelaar DJ, et al: Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle. J Virol. 65:3131–3139. 1991.PubMed/NCBI
6	Tavassoli M, Guelen L, Luxon BA and Gaken J: Apoptin: specific killer of tumor cells? Apoptosis. 10:717–724. 2005. View Article : Google Scholar : PubMed/NCBI
7	Noteborn MH: Proteins selectively killing tumor cells. Eur J Pharmacol. 625:165–173. 2009. View Article : Google Scholar : PubMed/NCBI
8	Guelen L, Paterson H, Gaken J, Meyers M, Farzaneh F and Tavassoli M: TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene. 23:1153–1165. 2004. View Article : Google Scholar : PubMed/NCBI
9	Danen-Van Oorschot AA, Fischer DF, Grimbergen JM, et al: Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci USA. 94:5843–5847. 1997.PubMed/NCBI
10	Danen-Van Oorschot AA, Zhang YH, Leliveld SR, et al: Importance of nuclear localization of apoptin for tumor-specific induction of apoptosis. J Biol Chem. 278:27729–27736. 2003.PubMed/NCBI
11	Heilman DW, Teodoro JG and Green MR: Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies. J Virol. 80:7535–7545. 2006. View Article : Google Scholar
12	Maddika S, Wiechec E, Ande SR, et al: Interaction with PI3-kinase contributes to the cytotoxic activity of apoptin. Oncogene. 27:3060–3065. 2008. View Article : Google Scholar : PubMed/NCBI
13	Maddika S, Bay GH, Kroczak TJ, et al: Akt is transferred to the nucleus of cells treated with apoptin, and it participates in apoptin-induced cell death. Cell Prolif. 40:835–848. 2007. View Article : Google Scholar : PubMed/NCBI
14	Jiang J, Cole D, Westwood N, et al: Crucial roles for protein kinase C isoforms in tumor-specific killing by apoptin. Cancer Res. 70:7242–7252. 2010. View Article : Google Scholar : PubMed/NCBI
15	Teodoro JG, Heilman DW, Parker AE and Green MR: The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. Genes Dev. 18:1952–1957. 2004. View Article : Google Scholar : PubMed/NCBI
16	Janssen K, Hofmann TG, Jans DA, Hay RT, Schulze-Osthoff K and Fischer U: Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies. Oncogene. 26:1557–1566. 2007. View Article : Google Scholar : PubMed/NCBI
17	Shi L, Nishioka WK, Th’ng J, Bradbury EM, Litchfield DW and Greenberg AH: Premature p34cdc2 activation required for apoptosis. Science. 263:1143–1145. 1994. View Article : Google Scholar : PubMed/NCBI
18	Kuusisto HV, Wagstaff KM, Alvisi G and Jans DA: The C-terminus of apoptin represents a unique tumor cell-enhanced nuclear targeting module. Int J Cancer. 123:2965–2969. 2008. View Article : Google Scholar : PubMed/NCBI
19	Murray AW: Recycling the cell cycle: cyclins revisited. Cell. 116:221–234. 2004. View Article : Google Scholar : PubMed/NCBI
20	Brown NR, Noble ME, Endicott JA and Johnson LN: The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat Cell Biol. 1:438–443. 1999. View Article : Google Scholar : PubMed/NCBI
21	Loog M and Morgan DO: Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates. Nature. 434:104–108. 2005. View Article : Google Scholar : PubMed/NCBI
22	Brotherton DH, Dhanaraj V, Wick S, et al: Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d. Nature. 395:244–250. 1998. View Article : Google Scholar : PubMed/NCBI
23	Jeffrey PD, Russo AA, Polyak K, et al: Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature. 376:313–320. 1995. View Article : Google Scholar : PubMed/NCBI
24	Honda R, Lowe ED, Dubinina E, et al: The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles. EMBO J. 24:452–463. 2005. View Article : Google Scholar : PubMed/NCBI
25	Los M, Panigrahi S, Rashedi I, et al: Apoptin, a tumor-selective killer. Biochim Biophys Acta. 1793:1335–1342. 2009. View Article : Google Scholar : PubMed/NCBI
26	Maddika S, Panigrahi S, Wiechec E, et al: Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin’s anticancer toxicity. Mol Cell Biol. 29:1235–1248. 2009.PubMed/NCBI
27	Golsteyn RM: Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis: a role beyond the cell cycle. Cancer Lett. 217:129–138. 2005. View Article : Google Scholar : PubMed/NCBI
28	Lee YH, Cheng CM, Chang YF, Wang TY and Yuo CY: Apoptin T108 phosphorylation is not required for its tumor-specific nuclear localization but partially affects its apoptotic activity. Biochem Biophys Res Commun. 354:391–395. 2007. View Article : Google Scholar : PubMed/NCBI
29	Poon IK, Oro C, Dias MM, Zhang J and Jans DA: Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res. 65:7059–7064. 2005. View Article : Google Scholar : PubMed/NCBI